<p>Brazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the Covid-19 vaccine developed by AstraZeneca and Oxford University has died, stating it had received data from an investigation into the matter.</p>.<p>The regulator said testing of the vaccine would continue after the volunteer's death. It provided no further details, citing medical confidentiality of those involved in trials.</p>.<p><strong>Also read — <a href="https://www.deccanherald.com/international/deceased-astrazeneca-trial-volunteer-didn-t-receive-vaccine-905410.html" target="_blank">Deceased AstraZeneca trial volunteer didn’t receive vaccine</a></strong></p>.<p>The Federal University of Sao Paulo, which is helping coordinate phase 3 clinical trials in Brazil, separately said that the volunteer was Brazilian but did not say where the person lived.</p>.<p>AstraZeneca shares turned negative and were down 1.7%.</p>.<p>The federal government already has plans to purchase the UK vaccine and produce it at its biomedical research center FioCruz in Rio de Janeiro, while a competing vaccine from China's Sinovac is being tested by Sao Paulo state's research center Butantan Institute.</p>.<p>Brazil has the second deadliest outbreak of coronavirus, with more than 154,000 killed by COVID-19, following only the United States. It is the third worst outbreak in terms of cases, with more than 5.2 million infected, after the United States and India.</p>
<p>Brazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the Covid-19 vaccine developed by AstraZeneca and Oxford University has died, stating it had received data from an investigation into the matter.</p>.<p>The regulator said testing of the vaccine would continue after the volunteer's death. It provided no further details, citing medical confidentiality of those involved in trials.</p>.<p><strong>Also read — <a href="https://www.deccanherald.com/international/deceased-astrazeneca-trial-volunteer-didn-t-receive-vaccine-905410.html" target="_blank">Deceased AstraZeneca trial volunteer didn’t receive vaccine</a></strong></p>.<p>The Federal University of Sao Paulo, which is helping coordinate phase 3 clinical trials in Brazil, separately said that the volunteer was Brazilian but did not say where the person lived.</p>.<p>AstraZeneca shares turned negative and were down 1.7%.</p>.<p>The federal government already has plans to purchase the UK vaccine and produce it at its biomedical research center FioCruz in Rio de Janeiro, while a competing vaccine from China's Sinovac is being tested by Sao Paulo state's research center Butantan Institute.</p>.<p>Brazil has the second deadliest outbreak of coronavirus, with more than 154,000 killed by COVID-19, following only the United States. It is the third worst outbreak in terms of cases, with more than 5.2 million infected, after the United States and India.</p>